Euro Diagnostica AB recalls DIASTAT(R) ANA (anti-Nuclear antibody) EURO DIAGNOSTICA, The DIASTAT(R) anti-nuclear antibody (ANA) test is a qualitati…
- Recall date
- May 22, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2627-2017
- FDA classification
- Class III
- Brand / firm
- Euro Diagnostica AB
- Sold / distributed
- MN, TX, NE, PA, Spain, Egypt, Pakistan, Nepal, Canada
Why it was recalled
FANA200 kit lot TS 3577 was re-worked due to shortened shelf-life. The alert sticker on the kit box of the lot informed customers that the shelf-life had been shortened and referenced a letter sent to customers for more information, where the new expiration date was stated. The original kit box label remained on the kit box stating the original expiration date, the packaging did not display the correct expiration date.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
DIASTAT(R) ANA (anti-Nuclear antibody) EURO DIAGNOSTICA, The DIASTAT(R) anti-nuclear antibody (ANA) test is a qualitative enzyme-linked immunosorbent assay (ELISA) for the detection of ANAs in human serum or EDTA plasma. It detects ANAs against Sm, Sm/RNP, Ro (SS-A), La (SS-B), Scl-70, Jo-1, dsDNA, histone and centromere antigens.
Get recall alerts
Free email alert whenever Euro Diagnostica AB has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Euro Diagnostica AB